US Edition
Your source for latest news
LifestyleConsumer Alert

FDA recalls two sexual-enhancement supplements found to contain hidden prescription drugs

Federal regulators recalled a honey-based supplement and a capsule product this week after lab testing found undeclared erectile-dysfunction drugs and acetaminophen, risks the companies say have caused no confirmed illnesses so far.

PN
By PressTemps NewsroomPublished Today, 05:10 ET · 5 min read
FDA recalls two sexual-enhancement supplements found to contain hidden prescription drugs
An illustrative photo of prescription tablets and a pill bottle; not the specific recalled products. Photo: The Javorac / Flickr, CC BY 2.0
What to know
Game Changer Products LLC recalled all lots of its 10 Day Forecast Capsules 3200mg after FDA testing found undeclared sildenafil and acetaminophen; the product was sold nationwide from October 2021 through October 17, 2026.
Eros Apothecary recalled one batch (241020) of Candy Power For Man Organic Honey, sold on eBay from April 27 to July 20, 2026, after testing found undeclared tadalafil.
Both sildenafil and tadalafil can cause a dangerous drop in blood pressure when combined with nitrate heart medications; the capsule's hidden acetaminophen adds a separate liver-injury risk.
The FDA says both recalls were voluntary, no confirmed adverse events have been reported, and the agency's hidden-ingredient database "covers only a small fraction" of similarly contaminated products on the market.

The Food and Drug Administration this week announced two separate recalls of over-the-counter sexual-enhancement products after laboratory testing found each one contained a hidden prescription drug that was not listed on its label. The recalls, posted the same day, involve a honey-based supplement and a capsule sold as a dietary aid, both marketed as natural alternatives to prescription erectile-dysfunction medication.

Tampa, Florida-based Game Changer Products LLC issued a voluntary nationwide recall of all lots of its 10 Day Forecast Capsules 3200mg after agency testing found the product contained undeclared sildenafil, the active ingredient in Viagra, along with undeclared acetaminophen. Separately, Eros Apothecary of Indio, California, recalled a single batch of its Candy Power For Man Organic Honey after testing turned up undeclared tadalafil, the active ingredient in Cialis. Neither ingredient appeared on the products' labels, which described them as dietary supplements rather than drugs.

What the testing found

The 10 Day Forecast capsules, sold in blue-and-black cards under UPC 191645852717, were distributed nationwide, including in Puerto Rico, Guam and the Northern Mariana Islands, from at least October 2021 through October 17, 2026, according to the FDA notice. Sales channels included the company's own website, eBay listings and a single retail store in Minnesota. The company said it is notifying customers directly by email and through eBay's messaging system and is working with the agency to pull remaining stock from circulation.

The Eros Apothecary recall is narrower in scope: it covers one lot, batch number 241020, with a listed expiration date of December 2029, sold through an eBay storefront between April 27 and July 20, 2026. Both companies described the recalls as voluntary and said they received no confirmed reports of adverse events tied to the products at the time the notices were posted.

Why the hidden ingredients matter

Sildenafil and tadalafil belong to a class of drugs called PDE5 inhibitors, approved by the FDA only as prescription medications precisely because of how they can interact with other drugs. Taken alongside nitrate medications, such as nitroglycerin prescribed for chest pain, either drug can cause blood pressure to drop to dangerous or life-threatening levels. People with diabetes, high blood pressure, high cholesterol or heart disease are especially likely to be on a nitrate, which is what makes undisclosed dosing so risky: a consumer with no prescription, and no pharmacist checking for interactions, has no way of knowing the product carries that hazard. The FDA's notice for the capsule recall adds that acetaminophen, the second undeclared ingredient, carries its own risk of liver damage and serious skin reactions when consumed unknowingly on top of other acetaminophen-containing products such as common pain relievers or cold medicine.

Both recalls fit a pattern the agency has documented for years. On its page about avoiding products contaminated with hidden ingredients, the FDA warns that supplements marketed for sexual performance, weight loss, bodybuilding, sleep or pain relief are the categories most frequently found to contain undisclosed pharmaceuticals. The agency maintains a public database of such products but is explicit about its limits.

"This database covers only a small fraction of the contaminated and/or fraudulent products on the market. If a product is not on the list, that does not mean it is safe."

Who is exposed, and why supplements slip through

The exposure runs through two separate but related gaps in how dietary supplements reach consumers. First, unlike prescription drugs, supplements do not require FDA approval before they go on sale; the agency generally acts only after a product is already in the marketplace, often following consumer complaints or its own laboratory sampling. Second, both recalled products were sold substantially or entirely through online marketplaces and company websites rather than pharmacies, meaning buyers never had a pharmacist in the loop to flag a dangerous drug interaction before purchase.

Anyone who bought either product, and in particular men who take nitrate medication for a heart condition, is advised to act on the following steps:

  • Stop using the product immediately and discard any remaining supply rather than returning it to a retailer.
  • Tell a doctor or pharmacist about having taken the product, especially before starting or resuming any heart medication, rather than adjusting a prescription without medical advice.
  • Watch for warning signs, including chest pain, fainting, severe dizziness or a racing heartbeat, and seek emergency care if they occur, mentioning the product to responders.
  • For the capsule recall specifically, watch for nausea, abdominal pain, dark urine or yellowing of the skin or eyes, which can signal the liver effects of unintentional extra acetaminophen.

Company response and what happens next

Both companies' recall notices, posted through the FDA's enforcement reporting system, describe the actions as voluntary and in cooperation with the agency. Eros Apothecary's notice directs customers with questions to an email address set up for the recall, while Game Changer Products' notice lists a phone line staffed on weekdays. Consumers or clinicians who believe they experienced a reaction linked to either product are directed to file a report with the FDA's MedWatch adverse event program, which the agency uses to track harm from products already on the market and to decide whether further enforcement action, including a mandatory recall, is warranted.

Coverage of the two recalls by outlets including Medical Daily and ConsumerLab has noted that the pairing of two unrelated recalls on the same day is not unusual; the agency routinely posts a steady stream of similar notices for sexual-enhancement products sold as honey, chocolate or capsules, most involving the same handful of undeclared PDE5 inhibitors. Neither recalled product has been reported to have caused confirmed harm so far, but the FDA's standing guidance remains that consumers who use any over-the-counter product marketed for sexual enhancement should discuss it with a doctor beforehand, since the label alone offers no guarantee of what the product actually contains.

More on this story

All Lifestyle